CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $31,000 | +933.3% | 69,689 | +905.5% | 0.00% | – |
| Q2 2018 | $3,000 | -99.9% | 6,931 | -99.5% | 0.00% | -100.0% |
| Q1 2018 | $3,340,000 | +19.5% | 1,433,340 | +45.7% | 0.01% | +30.0% |
| Q4 2017 | $2,794,000 | +2751.0% | 983,953 | +25240.0% | 0.01% | – |
| Q2 2015 | $98,000 | -58.8% | 3,883 | -54.5% | 0.00% | -100.0% |
| Q1 2015 | $238,000 | -51.6% | 8,528 | -68.4% | 0.00% | -66.7% |
| Q4 2014 | $492,000 | +1950.0% | 26,986 | +1328.6% | 0.00% | – |
| Q3 2014 | $24,000 | -42.9% | 1,889 | -26.7% | 0.00% | – |
| Q2 2014 | $42,000 | -80.4% | 2,576 | -78.7% | 0.00% | -100.0% |
| Q1 2014 | $214,000 | +1158.8% | 12,089 | +1659.7% | 0.00% | – |
| Q4 2013 | $17,000 | – | 687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $19,497,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $17,928,000 | 2.31% |
| TSP Capital Management Group, LLC | 1,278,057 | $3,630,000 | 1.65% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 10,772,111 | $30,593,000 | 0.46% |
| Virtus ETF Advisers LLC | 118,969 | $338,000 | 0.42% |
| Benchmark Capital Advisors | 61,000 | $173,000 | 0.14% |
| ASCEND CAPITAL, LLC | 873,995 | $2,482,000 | 0.09% |
| SHEPHERD KAPLAN KROCHUK, LLC | 44,521 | $126,000 | 0.08% |
| Vident Investment Advisory, LLC | 427,578 | $1,214,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $227,000 | 0.04% |